Commonly used tablet for BP put under scanner

March 26, 2010 06:17 pm | Updated November 18, 2016 08:23 pm IST - MADURAI:

A medicine (tablet) commonly used for treatment of high Blood Pressure and heart problems has been put under the scanner by the Directorate of Drug Control, Government of Tamil Nadu.

Drug Control officials in various places, including Madurai, have been asked to collect samples of the tablet, ‘Cardace-5,' of a particular batch number from the stockists and send them for investigation to be done at the Directorate level, official sources said here.

“We have received instructions from the Directorate of Drug Control, Chennai, to send strips of ‘Cardace-5' tablets. The tablets were taken from the wholesale distributors and sent them for analysis at the Drug Testing Laboratory on Thursday,” an official told The Hindu here.

M. Bhaskaran, Director of Drug Control, confirmed that the particular tablet was under investigation due to certain doubts. “The problem is not with regard to expiry date but something else. The details will be revealed at a later stage when the investigation in to the suspicions is completed,” he said.

According to sources, the verification of the tablet stocks is being done by collecting the distribution details in each place, and already 20 strips from Madurai had been collected and sent for investigation following the Directorate's instructions. “The reasons for suspicion are still not known. Whether it is spurious or anything else, it is not informed to us. The samples of Cardace-5 we had collected are from a batch that was released three months back,” a drug inspector here said.

In the last few days, the Directorate of Drug Control had seized bottles of a cough syrup from various places and sent them to laboratory for analysis. “The mode of investigation for Benadryl cough syrup and Cardace-5 is completely different. The results will be knownsoon.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.